TrialDiabetes, obesity & metabolism2026

Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.

Giacomo Ruotolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.